Gupta C, Braun A
Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania 15213.
Endocrinology. 1990 Jan;126(1):341-8. doi: 10.1210/endo-126-1-341.
The present study was designed to test whether phospholipase-A2 stimulatory protein (PLSP) has any role during androgen-induced masculine differentiation. Thus, an investigation was made to identify such a protein in the fetal genital tract and to test whether this protein can produce masculinization in vitro. Fetal tracts (15/batch) containing genital ducts and urogenital sinus from male, female, and testosterone-exposed (40 mg/kg.day, from days 13-17 of gestation) female embryonic mice on day 18 of gestation were fractionated using Bio-Rad P-100 gel filtration, DEAE-cellulose, and carboxymethyl-Sephadex chromatography. Phospholipase-A2 (PLA2) stimulatory activity was identified at every step of purification. The final preparation stimulated both bee venom and mouse genital PLA2; however, it had no effect on PLC. The preparation lost its PLA2 stimulatory activity after pronase treatment. The partially purified PLSP fraction produced two bands (63K and 55K), as determined by sodium dodecyl sulfate-gel electrophoresis, and its PLA2 stimulatory activity appeared at the region of 55K on a P-100 gel filtration column. PLSP was also identified in female and testosterone-exposed female genital tracts. However, the specific activity of the female PLSP was much lower than that of the male or testosterone-exposed females. Sodium dodecyl sulfate-gel analysis of 2-3 micrograms partially purified PLSP revealed the presence of a faint 55K band in the females compared to the presence of a darker 55K band in the male and testosterone-exposed female. The intensity of the 63K band was similar in both sexes. PLSP from the male and testosterone-exposed females maintained and stimulated the Wolffian duct, whereas PLSP from the female tract had no masculinizing effect. Thus, the masculinizing activity of the PLSP preparation appears to correlate with its PLA2 stimulatory activity and 55K band intensity, suggesting the role of PLA2 stimulatory protein in masculine differentiation.
本研究旨在测试磷脂酶 - A2 刺激蛋白(PLSP)在雄激素诱导的雄性分化过程中是否发挥作用。因此,开展了一项研究,以在胎儿生殖道中鉴定这种蛋白,并测试该蛋白在体外是否能产生雄性化作用。在妊娠第 18 天,使用伯乐 P - 100 凝胶过滤、DEAE - 纤维素和羧甲基 - 葡聚糖凝胶色谱法对来自雄性、雌性以及暴露于睾酮(40 毫克/千克·天,从妊娠第 13 - 17 天开始)的雌性胚胎小鼠的含有生殖管道和泌尿生殖窦的胎儿生殖道(每组 15 个)进行分级分离。在纯化的每一步都鉴定出了磷脂酶 - A2(PLA2)刺激活性。最终制剂对蜂毒和小鼠生殖道 PLA2 均有刺激作用;然而,它对 PLC 没有影响。经链霉蛋白酶处理后,该制剂失去了其 PLA2 刺激活性。通过十二烷基硫酸钠 - 凝胶电泳测定,部分纯化的 PLSP 组分产生了两条带(63K 和 55K),并且其 PLA2 刺激活性出现在 P - 100 凝胶过滤柱上 55K 的区域。在雌性和暴露于睾酮的雌性生殖道中也鉴定出了 PLSP。然而,雌性 PLSP 的比活性远低于雄性或暴露于睾酮的雌性。对 2 - 3 微克部分纯化的 PLSP 进行十二烷基硫酸钠 - 凝胶分析显示,与雄性和暴露于睾酮的雌性中较深的 55K 带相比,雌性中存在一条 faint 的 55K 带。63K 带的强度在两性中相似。来自雄性和暴露于睾酮的雌性的 PLSP 维持并刺激了中肾管,而来自雌性生殖道的 PLSP 没有雄性化作用。因此,PLSP 制剂的雄性化活性似乎与其 PLA2 刺激活性和 55K 带强度相关,这表明 PLA2 刺激蛋白在雄性分化中发挥作用。